Faster-acting insulin aspart improves postprandial glycaemia versus insulin aspart in patients with type 1 diabetes mellitus

被引：0
|
作者：
Heise, T. [1 ]
Haahr, H. [2 ]
Jensen, L. [2 ]
Erichsen, L. [2 ]
Hompesch, M. [3 ]
机构：
[1] Profil, Neuss, Germany
[2] Novo Nordisk AS, Soborg, Denmark
[3] Profil Inst Clin Res Inc, Chula Vista, CA USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
120
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] Faster-acting insulin aspart: faster offset of exposure and action in addition to faster onset in subjects with type 1 diabetes using continuous subcutaneous insulin infusion
    Zijlstra, E.
    Heise, T.
    Nosek, L.
    Rikte, T.
    Haahr, H.
    DIABETOLOGIA, 2016, 59 : S98 - S99
  • [42] Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
    Dovc, Klemen
    Spanbauer, Charles
    Chiarle, Eleonora
    Bratina, Natasa
    Frohlich-Reiterer, Elke
    Potocnik, Nejka
    Zaharieva, Dessi P.
    Hropot, Tim
    Fritsch, Maria
    Calhoun, Peter
    Battelino, Tadej
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2147 - 2153
  • [43] EARLIER ONSET OF EXPOSURE AND GREATER EARLY PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS FOR FASTER-ACTING INSULIN ASPART VERSUS INSULIN ASPART USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    Heise, T.
    Zijlstra, E.
    Rikte, T.
    Nosek, L.
    Haahr, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A20 - A20
  • [44] Higher Early Insulin Exposure and Greater Early Glucose-Lowering Effect with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Mellitus (T1DM)
    Haahr, Hanne
    Hoevelmann, Ulrike
    Brondsted, Lise
    Adrian, Charlotte L.
    Nosek, Leszek
    Heise, Tim
    DIABETES, 2014, 63 : A233 - A233
  • [45] Glycaemic efficacy and safety of mealtime faster-acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta-analysis of randomized controlled trials
    Pal, Rimesh
    Banerjee, Mainak
    Bhadada, Sanjay Kumar
    DIABETIC MEDICINE, 2021, 38 (03)
  • [46] Faster-acting insulin aspart by continuous subcutaneous insulin infusion: earlier exposure and greater early pharmacokinetic / pharmacodynamic effects vs insulin aspart
    Zijlstra, E.
    Heise, T.
    Rikte, T.
    Thorsson, L.
    Nosek, L.
    Haahr, H.
    DIABETOLOGIA, 2015, 58 : S452 - S452
  • [47] MECHANISTIC ANALYSIS INTO THE MODE(S) OF ACTION OF NIACINAMIDE IN FASTER-ACTING INSULIN ASPART
    Buckley, S. T.
    Kildegaard, J.
    Hoiberg-Nielsen, R.
    Jeppesen, C. Bekker
    Olsen, H. Birk
    Refsgaard, H. H. F.
    Ludvigsen, S.
    Ribel, U.
    Hostrup, S.
    Sturis, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A116 - A117
  • [48] EFFICACY AND SAFETY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OF FASTER ASPART COMPARED WITH INSULIN ASPART IN TYPE 1 DIABETES
    Klonoff, D.
    Evans, M.
    Lane, W.
    Kempe, H. P.
    Renard, E.
    DeVries, H.
    Graungaard, T.
    Hyseni, A.
    Battelino, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A32 - A33
  • [49] EVALUATION OF EARLY POSTPRANDIAL SUPPRESSION OF ENDOGENOUS GLUCOSE PRODUCTION WITH FASTER ASPART VERSUS INSULIN ASPART
    Pieber, T.
    Basu, A.
    Hansen, A. K.
    Sach-Friedl, S.
    Thomsen, K. M. D.
    Basu, R.
    Haahr, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A33 - A33
  • [50] Faster-Acting Insulin Aspart: Towards an Understanding of the Mechanism(s) of Action of Nicotinamide
    Buckley, Stephen T.
    Jeppesen, Claus B.
    Olsen, Helle B.
    Hostrup, Susanne
    Sturis, Jeppe
    DIABETES, 2015, 64 : A262 - A262
12345